日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut

DRD2 缺陷是垂体腺瘤的根本原因,该腺瘤依赖于大肠杆菌从肠道的移位。

Su, Xian-Jun; Ma, Li; Xiong, Xi; Meng, Jun-Hua; Wu, Qi; Zhang, Yu; Dong, Shu-Guang; Wang, Yue-Fei; Wu, Jin-Hu; Zeng, Qing-Yuan; Zhang, Hong-Feng; Li, Li-Li; Meng, Liang; Peng, Min; Huang, Xiao-Dong; Wu, Li-Quan; Wang, Xiong

Associations of Albuminuria and Metabolic Syndrome Traits With Fracture Risk in Patients With Type 2 Diabetes: A Population-Based Cohort Study

2型糖尿病患者蛋白尿和代谢综合征特征与骨折风险的关联:一项基于人群的队列研究

Xiong, Xi; Lui, David T W; Ju, Chengsheng; Liu, Xiaodong; Wei, Li; Chandran, Manju; Wong, Carlos K H

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study

尼马曲韦/利托那韦和莫努匹韦对老年人群新冠后糖尿病风险的影响:一项目标试验模拟研究

Guo, Zihao; Wei, Yuchen; Yang, Aimin; Wong, Carlos King Ho; Xiong, Xi; Wang, Kailu; Lin, Guozhang; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Zhao, Shi; Mok, Chris Ka Pun; Hui, David S C; Yeoh, Eng Kiong; Chong, Ka Chun

Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications

探索晚期帕金森病伴运动并发症患者的粪便微生物群失调及其血浆代谢组决定因素

Qian, Shuangjie; Hou, Jialong; Xiong, Xi; Duan, Qi; Jiang, Tao; Zheng, Yi; Quan, Weiwei; Xu, Jiaxue; Chen, Keke; Qian, Jingjing; Gao, Hongchang; Xie, Chenglong

Continuous renal replacement therapy attenuates endothelial injury biomarkers in pediatric sepsis: a prospective cohort study

连续性肾脏替代疗法可减轻儿童脓毒症中的内皮损伤生物标志物:一项前瞻性队列研究

Miao, Huijie; Wang, Chunxia; Cui, Yun; Xiong, Xi; Ren, Yuqian; Lv, Zhibao; Zhang, Yucai

Effectiveness of solution-focused brief therapy on cancer patients: a systematic review and meta-analysis

以解决方案为中心的短期疗法对癌症患者的疗效:系统评价和荟萃分析

Zhou, Luqiang; Yuan, Xiaojuan; Li, Yan; Li, Siyue; Guo, Fang; Song, Caiping; Chen, Yu; Xiong, Xi

iMeta Conference 2025: Creating high-impact international journals

2025年iMeta会议:创建高影响力国际期刊

Zhu, Zhihao; Zhang, Lin; Yao, Xiaofang; Zeng, Meiyin; Wang, Yao; Luo, Hao; Zhou, Yuanping; Zhang, Tianyuan; Xun, Jiani; Bai, Defeng; Yang, Haifei; Xu, Shanshan; Zhou, Yang; Gao, Yunyun; Xu, Jinbo; Han, Wei; Shen, ZiAng; Zhang, Bangzhou; Ma, Tengfei; Wan, Xiu-Lin; Ma, Chuang; Hui, Fengjiao; Bai, Hao; Bai, Lijing; Bai, Qing; Bao, Qiangguo; Cao, Guodong; Cao, Peng; Cao, Qiqi; Chen, Hu; Chen, Jiawen; Chen, Jiaxu; Chen, Lihua; Chen, Tingting; Chen, Yi; Cui, Haipeng; Dai, Shaoxing; Dai, Xi-Jian; Dai, Xiaofeng; Dang, Yanqi; Deng, Lei; Deng, Yun; Ding, Xia; Dong, Binhua; Dong, Ling; Dou, Shujie; Du, Hongzhi; Fang, Zhencheng; Feng, Xiaoxiao; Fu, Min; Gao, Yuan; Gong, Wenping; Guo, Xiang; Han, Wenjie; Hao, Zikai; He, Zheng-Guo; Hu, Haibo; Hu, Haiming; Hu, Xuefei; Huang, Liang; Huang, Xianya; Huang, Xueting; Hui, Haochen; Jia, Dingjiacheng; Jiang, Aimin; Jiang, Di; Jiang, Kun; Jiang, Dewei; Jin, Ying; Lai, Kunyang; Li, Chun; Li, Feng; Li, Fuyong; Li, Jing; Li, Juan; Li, Junling; Li, Kui; Li, Ling; Li, Moli; Li, Peiwu; Li, Peng; Li, Runze; Li, Shengnan; Li, Shujin; Li, Wanting; Li, Wenting; Li, Xiaojing; Li, Xinrui; Li, Xuemeng; Liang, Qiqi; Liao, Xiaoping; Liu, Boyang; Liu, Canzhao; Liu, Chang; Liu, Duanrui; Liu, Furong; Liu, Jianjun; Liu, Jinyao; Liu, Siqi; Liu, Tianyang; Liu, Wenjuan; Liu, Yan; Liu, Yang; Liu, Yi; Liu, Yuan; Liu, Yunhuan; Liu, Zhipeng; Liu, Zhiyong; Lu, Xin; Luo, Xiao; Ma, Guanju; Meng, Jialin; Meng, Yuanfa; Miao, Runyu; Miao, Linxuan; Ni, Yawen; Niu, Dongze; Niu, Tingting; Pan, Hongzhao; Qin, Guoqiang; Qiu, Tiantian; Qiu, Yueping; Qu, Hui; Qu, Linghang; Ren, Na; Sun, Qiang; Shang, Run; She, Peize; Shen, Xihui; Shi, Bohan; Shu, You; Song, Jiawei; Song, Weibin; Su, Qi; Sun, Qingzhu; Sun, YuPing; Sun, Zijin; Tang, Bufu; Tang, Deqin; Tang, Hua; Tao, Yongfu; Teng, Teng; Tu, Yanye; Wang, Cheng; Wang, Hui; Wang, Yunhao; Wang, Chunli; Wang, Dingjie; Wang, Gang; Wang, Jin; Wang, Kaiyi; Wang, Mingbang; Wang, Shan; Wang, Shixiang; Wang, Xiaojie; Wang, Xing-Chang; Wang, Yunzhe; Wang, Jiale; Wang, Zheng; Wang, Weijie; Wei, Yongjun; Xu, Wei; Wu, Fan; Wu, Junling; Wu, Shijuan; Xiao, Jian; Xiao, Weihua; Xiao, Yang; Xiong, Xi; Xiong, Xue; Xu, Feng; Xu, Junyu; Xu, Wen; Xu, Jun; Xu, Yao; Yan, Jun; Yao, Lutian; Yang, Jia; Yang, Lulu; Yang, Xingzhen; Yin, Naiyi; You, Hua; You, Min; Yu, Ting; Yu, Yongyao; Yu, Renqiang; Yuan, Shuofeng; Yue, Chaoxiong; Zeng, Xiaoya; Zha, Andong; Zhai, Leilei; Zhang, Chi; Zhang, Dong; Zhang, Hengguo; Zhang, Heng; Zhang, Hongyu; Zhang, Jiahao; Zhang, Jinyang; Zhang, Lishan; Zhang, Qi; Zhang, Xiang; Zhang, Xiangyu; Zhang, Xuelei; Zhang, Yancong; Zhang, Yuan; Zhang, Zhenyu; Zhao, Jiwei; Zhao, Jingxuan; Zhao, Kai; Zhao, Mingjuan; Zhao, Yi; Zhao, Yunxiang; Zhong, Jixin; Zhong, Ling; Zhong, Xiangjian; Zhou, Dan; Zhou, Wei; Zhou, Wen; Zhou, Yiqian; Zhou, Zhemin; Zhu, Shiquan; Liu, Shuang-Jiang; Feng, Suyin; Jin, Shuangxia; Xiao, Chuanxing; Wang, Ziheng; Luo, Peng; Chen, Tong; Chen, Gang; Liu, Yong-Xin

Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

立即启动尼马曲韦-利托那韦治疗对新冠肺炎后预后更有益:一项基于人群的回顾性队列研究

Chong, Ka Chun; Wei, Yuchen; Wong, Carlos King Ho; Xiong, Xi; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Guo, Zihao; Li, Kehang; Yang, Aimin; Mok, Chris Ka Pun; Hui, David S C; Zhao, Shi; Yeoh, Eng Kiong; Lin, Guozhang

Parathyroidectomy and Risk of Incident Diabetes in Patients With Primary Hyperparathyroidism

甲状旁腺切除术与原发性甲状旁腺功能亢进患者发生糖尿病的风险

Liu, Xiaodong; Lui, David Tak Wai; Xiong, Xi; Li, Lanlan; Luk, Yan; Wong, Chun Ho; Lee, Chi Ho; Wong, Carlos King Ho; Fung, Matrix Man Him; Lang, Brian Hung Hin

NAD+-Boosters Improve Mitochondria Quality Control In Parkinson's Disease Models Via Mitochondrial UPR.

NAD+增强剂通过线粒体UPR改善帕金森病模型中的线粒体质量控制。

Zhou Shuoting, Xiong Xi, Hou Jialong, Duan Qi, Zheng Yi, Jiang Tao, Huang Jiani, He Haijun, Xu Jiaxue, Chen Keke, Wang Wenwen, Cai Jinlai, Qian Jingjing, Chen Huijun, Song Weihong, Wang XinShi, Xie Chenglong